Chosen as one of only eight companies worldwide to present at the 2025 Global MedTech Showcase.
AVaTAR MedTech is proud to announce its selection as one of only eight companies worldwide to present at the One Six 8 Ventures Global MedTech Showcase, chosen from a pool of more than 100 innovative organizations across 14+ countries.
The event will take place on November 20, 2025, at 4:30 PM EDT, offering a global platform to share how AVaTAR MedTech is advancing cardiac surgery through innovation, precision, and new possibilities for patients with semilunar valve disease.
This showcase brings together top innovators, investors, and leaders in MedTech, creating a unique opportunity to present breakthrough technologies shaping the future of healthcare.
The event is supported by leading organizations, including:
BLPN, Health Campus Limburg DC, Creative Destruction Lab, Calgary Economic Development, BioAlberta, OBIO, Montréal InVivo, Biovia, Mintz, bene : studio, TD, and AxialBridge.
Being selected for this global stage underscores the impact of our mission and the growing recognition of our surgical innovation in valve reconstruction.
